Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis
Abstract Background The number of patients treated with extracorporeal membrane oxygenation (ECMO) devices is increasing. Anticoagulation therapy is crucial to prevent thrombosis during ECMO therapy. Predominantly, heparin has been used as primary anticoagulant but direct thrombin inhibitors (DTI) h...
Main Authors: | René M’Pembele, Sebastian Roth, Aljoscha Metzger, Anthony Nucaro, Alexandra Stroda, Amin Polzin, Markus W. Hollmann, Giovanna Lurati Buse, Ragnar Huhn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-022-00401-2 |
Similar Items
-
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01) -
The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors
by: Cindy Neunert, et al.
Published: (2022-07-01) -
Anticoagulation Management during Extracorporeal Membrane Oxygenation—A Mini-Review
by: Filip Burša, et al.
Published: (2022-12-01) -
Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting
by: Matthias Klingele, et al.
Published: (2020-01-01) -
Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)